Bryn Mawr Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Bryn Mawr Capital Management's AMGN Position: Q2 2026 in Review
Bryn Mawr Capital Management increased its Amgen (AMGN) stake by 7.6% in Q2 2026, buying an estimated $232K and bringing the position to 9,560 shares worth $3.46M. The position accounts for 0.15% of the portfolio, ranked #124.
Bryn Mawr Capital Management first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.15M in Q3 2023. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Bryn Mawr Capital Management held 9,560 shares of Amgen worth $3.46M as of Q2 2026.
- Bryn Mawr Capital Management bought 678 Amgen shares in Q2 2026, an estimated $232K.
- Amgen made up 0.15% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #124 holding.
- Bryn Mawr Capital Management first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
- Bryn Mawr Capital Management's Amgen position peaked at $5.15M in Q3 2023.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.